Toxicity, efficacy, plasma drug concentrations and protease mutations in patients with advanced HIV infection treated with ritonavir plus saquinavir. Swiss HIV Cohort Study
Contributeurs/tricesLorenzi, P.; Yerly Ferrillo, Sabine; Abderrakim, K.; Fathi, Marc; Rutschmann, Olivier Thierry; von Overbeck, J.; Leduc, D.; Perrin, Luc; Hirschel, Bernard
Publié dansAIDS, vol. 11, no. 12, p. F95-99
Date de publication1997
Résumé
Mots-clés
- Acquired Immunodeficiency Syndrome/blood/ drug therapy
- Anti-HIV Agents/adverse effects/pharmacokinetics/ therapeutic use
- CD4 Lymphocyte Count
- CD4-CD8 Ratio
- Cohort Studies
- Drug Resistance, Microbial
- Drug Therapy, Combination
- Female
- HIV Protease/ genetics
- HIV Protease Inhibitors/adverse effects/pharmacokinetics/ therapeutic use
- Humans
- Male
- Mutation
- Pilot Projects
- Ritonavir/adverse effects/pharmacokinetics/ therapeutic use
- Saquinavir/adverse effects/pharmacokinetics/ therapeutic use
- Viremia/drug therapy
Structure d'affiliation
Citation (format ISO)
LORENZI, P. et al. Toxicity, efficacy, plasma drug concentrations and protease mutations in patients with advanced HIV infection treated with ritonavir plus saquinavir. Swiss HIV Cohort Study. In: AIDS, 1997, vol. 11, n° 12, p. F95–99. doi: 10.1097/00002030-199712000-00002
Fichiers principaux (1)
Article
Identifiants
- PID : unige:7419
- DOI : 10.1097/00002030-199712000-00002
- PMID : 9342060
ISSN du journal0269-9370